Well Hectort I don't think salaries are going to eat up $5.5 million in 18 months. They can manufacture IgM antibodies at scale, they have not passed 1 of 11 tests required by the manufacturer. They have stated that this problem can be fixed for ~$1m. They also keep getting patents granted
None of the major shareholders (to my knowledge) have sold any shares. All of your questions are very relevant and should be answered however as I've posted previously the PAB management doesn't appear to want to give any but the minimum information required. My question is "WHY?"
Well Hectort I don't think salaries are going to eat up $5.5...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1773666 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 3325244 | 5 |
View Market Depth
| Last trade - 07.00am 16/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable